Photonis is involved in latest JAXA Space Mission, XRISM
Aug 28th 2023
Markets
Lifescience
Brands
Photonis
Technologies
X-Ray technology
Photonis is proud to be part of the X-ray Imaging and Spectroscopy Mission (XRISM).
On August 26th, 2023, The Japan Aerospace Exploration Agency (JAXA) successfully launched their X-ray Imaging and Spectroscopy Mission (XRISM) Photonis’ Modulated X-Ray Sources (MXS) on-board.
Photonis is proud to be part of the X-ray Imaging and Spectroscopy Mission (XRISM) mission from JAXA (Japan Aerospace Exploration Agency), which will be launched on August 26th, 2023.
As a collaborative effort between JAXA and NASA, and with assistance from the ESA, the XRISM mission will observe X-Rays released by extreme phenomena to assist Scientists in studying the evolution of our universe. Targets for the XRISM mission include supernova remnants, binary systems with stelar-mass black holes, galaxies powered by supermassive black holes, and vast clusters of galaxies.
“XRISM is a new X-Ray astronomical satellite which observes plasma in stars and galaxies. With a new generation of X-Ray imaging spectroscopy technologies, XRISM will resolve mysteries regarding the formation of the universe” (JAXA)
The payload of the XRISM mission contains two scientific instruments, Resolve, a Microcalorimeter Spectrometer, and Xtend, a Wide-Field X-Ray Imager. In collaboration with SRON (Netherlands Institute for Space Research), Photonis developed and supplied Modulated X-Ray Sources (MXS), which are essential for accurately calibrating the energy scale of the Resolve Instrument.
For a complete information on the mission with launch, videos and interviews:
Visit Exosens at VISION 2024 - Booth 8C26, Hall 8 in Stuttgart. VISION 2024 is the world’s leading exhibition for machine vision technologies and system integrators.
Exosens (Euronext FR001400Q9V2 – EXENS), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology components, achieved consolidated revenue of €186.9 million for the first half 2024.
EXOSENS S.A. (Euronext Paris: FR001400Q9V2) announces today the implementation of a liquidity agreement with Kepler Cheuvreux to enhance the liquidity of EXOSENS shares admitted to trading on Euronext Paris....
Exosens S.A. (Compartment A, ISIN code FR001400Q9V2, ticker symbol « EXENS »), a high-tech company focused on providing mission and performance-critical amplification, detection...
In light of strong demand from investors in the placement, Exosens today announces that it increases the size of the Offering in the context of its initial public offering to 350 million euros...
In light of strong demand from investors in the placement, Exosens today announces that it increases the size of the Offering in the context of its initial public offering to 350 million euros...
Exosens launches today its initial public offering on Euronext Paris through a private placement. The main purpose of the IPO is to enable the Group to reduce its debt in order to increase its financial flexibility...
Stay connected
Stay informed and connected with Exosens' latest solutions and innovations by subscribing.